Cancer Immunotherapy Patient Advocate Tim Tuttle Shares His Treatment Success Story
Cancer Immunotherapy Patient Advocate Tim Tuttle Shares His Treatment Success Story
SITC patient advocate Tim Tuttle was diagnosed with Renal Cell Cancer about a year and a half ago. After receiving Cancer Immunotherapy treatment he is one the path to recovery as cancer tumors in his body are no longer discernible in CT scans.
Learn more about the Society for Immunotherapy of Cancer at: www.sitcancer.org
Immunotherapy News from China
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
- UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
- …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
- …Dosed in First-in-Human Clinical Study of Immunotherapy …
- JITC tumor and cancer immunotherapy papers collection
- Welcome to the submission|Journal for ImmunoTherapy of Cancer
- Immunotherapy shows promise for advanced lymphoma: study
- …from the Monotherapy Arm at the Phacilitate Immunotherapy …
- Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
Leave a Reply
You must be logged in to post a comment.